Subscribe to Business

The Lead

Capsugel unveils new spray-dried dispersion commercial manufacturing facility

July 1, 2015 8:31 am | Capsugel | News | Comments

Capsugel announced that it has completed construction of a new pharmaceutical spray-dried dispersion (SDD) commercial manufacturing facility at its site in Bend, Ore. The completion represents the final phase of a two-year, $25 million investment....

Ritter Pharmaceuticals, Inc. announces closing of $20,000,000 IPO

July 1, 2015 7:59 am | by BUSINESS WIRE | News | Comments

Ritter Pharmaceuticals, Inc., a pharmaceutical company developing novel therapeutic products...

Personalized medicine market to surpass $60 billion by 2019

June 18, 2015 12:50 pm | by PRESSWIRE | News | Comments

Cutting-edge new research by KellySciPub indicates that the core personalized medicine market...

Allergan purchasing Kythera Biopharmaceuticals for $2.1 billion

June 18, 2015 12:38 pm | News | Comments

In recent news, Allergan will be purchasing Kythera Biopharmaceuticals for $2.1 billion. With...

View Sample

FREE Email Newsletter

Bristol-Myers Squibb is an overvalued company in an expensive sector

June 18, 2015 12:35 pm | by Seeking Alpha | News | Comments

In my view, the market is set to crash at a certain point in the future. The reason? If the FED raises interest rates, then the value of stocks are due to fall. That's mainly because the discount factor employed as the denominator of the future free cash flows ...

NanoSphere unveils cannabinoids delivery system

June 18, 2015 11:38 am | News | Comments

NanoSphere Health Sciences is the first and only patent-pending nanoparticle delivery system for medical and recreational cannabis.

Pharmaceutical industry venture capital jumps in 2014

June 18, 2015 11:32 am | by Andy Szal, Digital Reporter | News | Comments

During the first 11 months of 2014, the industry saw $15.3 billion in venture capital compared to $11.5 billion in the first 11 months of 2013.


Teva and Microchips Biotech partner on digital drug delivery

June 18, 2015 11:11 am | by Business Wire | News | Comments

“The microchip-based implant is truly at the intersection of digital technology and medicine and the future of drug delivery for patients who cannot tolerate needles,” stated Michael Hayden, MD, PhD, Teva’s President of Global R&D and Chief Scientific Officer.

Arrowhead Gold to acquire Bio Therapeutic Molecules

June 18, 2015 11:08 am | News | Comments

Pursuant to the agreement, Arrowhead will acquire all shares of BTMI from the BTMI shareholders in exchange for 41.5 million common shares of Arrowhead.

Pancreatic cancer treatment pipeline dominated by early-stage development

June 17, 2015 12:05 pm | by GBI Research | News | Comments

While the pancreatic cancer treatment pipeline contains 447 therapeutics in active development across all phases, compared to 209 currently-marketed products, almost 75 percent of therapies are in Phase I or earlier.

Acura partners with Bayer on methamphetamine technology

June 17, 2015 12:00 pm | by Marketwired | News | Comments

Methamphetamine is a highly addictive drug and its production can be highly flammable.

Report ranks Abilify as top-selling drug

June 17, 2015 11:54 am | by Andy Szal, Digital Reporter | News | Comments

The antipsychotic medication for treatment of depression, bipolar disorder and schizophrenia totaled $7.2 billion in sales between June 2013 and June 2014.


Sandoz seeks to overturn $38M judgement

June 17, 2015 11:49 am | by The Associated Press | News | Comments

A drug manufacturer is asking the Mississippi Supreme Court to reverse a $38.2 million judgment for the state in a Medicaid drug-pricing lawsuit.

Greengro to develop cannabis products with Native American tribes

June 17, 2015 11:46 am | News | Comments

Greengro was recently featured on Forbes list of "hottest marijuana companies" and continues to gain momentum.

Tribute Pharmaceuticals acquires Medical Futures

June 17, 2015 11:36 am | News | Comments

The acquisition further diversifies Tribute's product portfolio in Canada through the addition of 13 marketed and two pipeline products.

Botox maker Allergan adds 'double-chin' drug with $2.1B deal

June 17, 2015 11:32 am | by The Associated Press | News | Comments

Botox maker Allergan Plc. is buying Kythera Biopharmaceuticals for about $2.1 billion, adding a drug that destroys fat cells and eliminates the cosmetic condition referred to as "double chin".

Survey: Americans blame pharmaceutical companies for high drug prices

June 16, 2015 4:11 pm | by Andy Szal, Digital Reporter | News | Comments

The June Kaiser Health Tracking Poll found that nearly three-quarters of respondents believed prescription drug costs are unreasonable, and that of those participants, 76 percent believed drug companies set their prices too high.


Pharma pipeline value jumps to $493B

June 16, 2015 11:26 am | by Business Wire | News | Comments

Prescription drug sales are forecasted to grow nearly 5% annually over the next five years.

BDI Pharma reports year-to-date revenues up 37%

June 16, 2015 11:12 am | by PR Newswire | News | Comments

One driver for the company's success is the increased emphasis on strategic partnerships with manufacturers.

Deloitte report: Open R&D models increase chances for late-stage success

June 15, 2015 12:02 pm | by PR Newswire | News | Comments

Deloitte's report suggests that biopharmaceutical companies could have greater success if they collaborate with other organizations — even competitors — as part of an open innovation approach to research and development.

Actavis changes name

June 15, 2015 11:51 am | News | Comments

The combination of Allergan and Actavis created one of the world's top 10 pharmaceutical companies by revenue and a leader in a new industry model.

Target selling pharmacy, clinic businesses to CVS Health

June 15, 2015 11:33 am | by TOM MURPHY, AP Business Writer | News | Comments

Target will sell its pharmacy and clinic businesses to the drugstore chain for about $1.9 billion in a deal that combines the resources of two retailers seeking to polish their health care reputations.

New England Biolabs announces plans for GMP manufacturing

June 12, 2015 11:16 am | News | Comments

The plans include the construction of a new 30,000 square foot, state-of-the-art, fully GMP-compliant cleanroom facility.

Walgreens recalls bottles of women's multivitamins

June 12, 2015 11:11 am | by The Associated Press | News | Comments

Walgreens Boots Alliance, Inc. is recalling a line of women's multivitamins because the packaging is not child-resistant.

Novartis gains FDA approval for childhood blood disorder drug

June 12, 2015 11:08 am | by PRNewswire | News | Comments

ITP affects as many as 5 in 100,000 children each year and is characterized by a low platelet count.

Axovant doubles in value after $315M IPO

June 12, 2015 10:57 am | by The Associated Press | News | Comments

Shares of Axovant Sciences nearly doubled in value after the dementia drug developer said its initial public offering raised $315 million, more than Axovant had expected.

Carna announces collaboration with J&J

June 11, 2015 11:22 am | by Business Wire | News | Comments

Carna Biosciences today announced a worldwide licensing agreement with Janssen Biotech to further develop and commercialize compounds from one of Carna Bioscience’s small molecule protein kinase inhibitor programs.

Murder charges for woman who took pills to terminate pregnancy

June 10, 2015 11:42 am | by Russ Bynum, Associated Press | News | Comments

"I have been involved in the pro-life movement for well over 20 years, and I'm not aware of a situation like this ever," said Genevieve Wilson, of Georgia Right to Life.

New Hemp Distribution Business

June 10, 2015 11:12 am | by PRNewswire | News | Comments

The new Sipp Industries Hemp unit will have large-volume hemp ingredients available, including toasted hemp seeds, hulled hemp seeds, hemp protein powder, cold-pressed hemp oil, and purely refined hemp oil.

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.